Log In
Print
BCIQ
Print
Print this Print this
 

BromSite (ISV-303)

  Manage Alerts
Collapse Summary General Information
Company InSite Vision Inc.
DescriptionLow-dose bromfenac, an NSAID, delivered via InSite's DuraSite sustained delivery technology
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard Indication Ophthalmic (unspecified)
Indication DetailsTreat inflammation and eye pain; Treat ocular inflammation and pain after cataract surgery
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today